IRIS
BRUGNOLO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.742
Totale 8.742
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.742
Totale 8.742
Salva come PNG Salva come JPEG
Città #
Genova 6.358
Rapallo 1.189
Genoa 952
Vado Ligure 209
Bordighera 34
Totale 8.742
Salva come PNG Salva come JPEG
Nome #
An updated Italian normative dataset for the Stroop color word test (SCWT) 166
Visual Versus Semi-Quantitative Analysis of 18F-FDG-PET in Amnestic MCI: An European Alzheimer's Disease Consortium (EADC) Project. 164
MCI Patients Declining and Not-Declining at Mid-Term Follow-up: FDG-Pet Findings. 153
A normative study of the Italian printed word version of the free and cued selective reminding test 148
Brain 18F-DOPA PET and cognition in de novo Parkinson's disease. 145
The Short Cognitive Evaluation Battery in Cognitive Disorders of the Elderly - Italian Version. 135
Radionuclide brain imaging correlates of cognitive impairment in Parkinson's disease (PD). 128
Un nuovo parametro grafopatologico nella valutazione dello stato cognitivo: l'indice della scrittura. 128
Brain dopaminergic (FluroDOPA PET) correlates of kinematic flexibility in Parkinson's Disease 127
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer Disease Consortium project 127
Brain perfusion correlates of cognitive and nigrostriatal functions in de novo Parkinson's disease. 125
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study 124
99mTc-HMPAO and 99mTc-ECD SPECT uptake correlates of verbal memory in Alzheimer’s disease 124
Cortical sources of awake scalp EEG in eating disorders 124
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. 124
How legislation on decisional capacity can negatively affect the feasibility of clinical trials in patients with dementia. 124
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. 120
The factorial structure of the mini mental state examination (MMSE) in Alzheimer's disease. 120
Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease 120
The Von Restorff effect in ageing and Alzheimer's disease. 119
Alterations in the autonomic control of heart rate variability in patients with anorexia or bulimia nervosa: correlations between sympathovagal activity, clinical features, and leptin levels 117
What predicts cognitive decline in de novo Parkinson's disease? 117
Functional neuroimaging and clinical features of drug naive patients with de novo Parkinson's disease and probable RBD 117
The reversed Clock drawing test phenomenon in Alzheimer’s disease: a perfusion SPECT study 116
Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers 116
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report 116
Spect predictors of cognitive decline and alzheimer's disease in mild cognitive impairment 112
Unawareness of Memory Deficit in Amnestic MCI: FDG-PET Findings 112
Global cognitive impairment should be taken into account in SPECT-neuropsychology correlations: the example of verbal memory in very mild Alzheimer's disease. 111
Parkinson’s Disease Sleep Scale 2: application in an Italian population 111
Cognitive-nigrostriatal relationships in de novo, drug-naïve Parkinson's disease patients: a [I-123]FP-CIT SPECT study. 110
Volume of interest-based [(18)F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. 109
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. 106
Amnestic mild cognitive impairment in Parkinson’s disease: a brain perfusion SPECT study 104
Early identification of MCI converting to AD: a FDG PET study 101
The reversed clock drawing test phenomenon in Alzheimer's disease: A perfusion SPECT study 100
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? 99
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. 97
Unawareness of memory deficit in amnestic MCI: FDG-PET findings. 92
The value of SPECT in detecting Alzheimer-type neurodegeneration in mild cognitive impairment 92
Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI 90
The influence of nigrostriatal dopaminergic dysfunction on cognition of de novo Parkinson's disease patients 89
Cognitive function in patients with carotid stenosis: preliminary data on the use of the WAIS-R. 89
MCI patients declining and not declining at mid-term follow-up: FDG PET findings. Annual Congress of the European Association of Nuclear Medicine 89
Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease. 89
MMSE factorial analysis in Alzheimer’s disease. 87
Italian validation of the Wagnild and Young Resilience Scale: a perspective to rheumatic disease Clin Exp Rheumatol 87
Principal component analysis of FDG PET in amnestic MCI 86
What predicts future cognitive decline in de novo Parkinson’s disease (PD)? 86
99mTc-HMPAO and 99mTc-ECD brain distribution correlates differently with verbal memory performance in Alzheimer’s disease patients 85
SPECT-Memory correlation in very mild Alzheimer’s disease. Effect of correlation for the severity of global cognitive impairment. 85
Cognitive impairment in late life bipolar disorder: Risk factors and clinical outcomes 85
Metabolic correlates of rey auditory verbal learning test in elderly subjects with memory complaints 85
Correlazioni SPECT-neuropsicologia nella malattia di Alzheimer iniziale 84
The fate of patients with REM sleep behavior disorder and Mild Cognitive Impairment 84
Dehydroepiandrosterone sulphate and its correlation with clinical and hormonal parameters in eating disorders. 82
Do we need a 99mTc-ECD template for SPM SPECT studies? 81
Metabolic Networks Involved in Cognitive Reserve in Prodromal Alzheimer's Disesase (pAD): A European Alzheimer's Disease Consortium (EADC) Project 81
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer’s disease 81
Brain dopaminergic correlates of cognitive functions in de novo parkinson’s disease: a 18FDOPA PET study. 80
18F–FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer’s disease (AD) patients at the mild cognitive impairment (MCI) stage 79
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data 79
The need of appropriate brain spect templates for spm comparisons 77
Brain Resources: How Semantic Cueing Works in Mild Cognitive Impairment due to Alzheimer’s Disease (MCI-AD) 76
Performance of [18F] FDG-PET in 142 MCI patients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC) 75
Cognitive correlates of nigrostriatal dysfunction in de novo Parkinson’s disease (PD) 74
Mapping memory impairment and conversion patterns in aMCI patients: a combined VBM and PET study 71
The visual search test: analysis of sensitivity of the global score and of the three items in mild Alzheimer’s disease 70
null 70
Cortical sources of awakening scalp EEG in eating disorders. 70
Principal component analysis of FDG PET in amnestic MCI 68
Anatomical and neurochemical bases of theory of mind in de novo Parkinson's Disease 68
null 67
Semantic memory impairment and geographic space recognition in Alzheimer’s disease 67
Funzioni attentive nell’anoressia nervosa: dati neurofisiologici preliminar 66
Integrated neurophysiological approach to Parkinson’s disease: preliminary data. 66
Dopaminergic Activity and Cognitive Function in de novo Parkinson Disease patients: an 18F-DOPA PET/CT study 66
The role of anterior prefrontal cortex in prospective memory: an exploratory FDG-PET study in early Alzheimer's disease 66
Consistency of neuropsychiatric syndromes across dementias: Results from the european alzheimer disease consortium. Part ii 65
Manuale del Caregiver – Per chi si prende cura della persona malata di Alzheimer 62
Is Euro a cognitive chellenge for the elderly? 61
Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study 61
Nigrocaudate dopaminergic impairment predict future cognitive decline in de novo parkinson’s disease (PD) 59
The organization of the neuropsychiatric "macro"- UVA at IRCCS AOU "San Martino-IST", Genova. 58
The Stroop color and word test (SCWT): preliminary normal data in an Italian population 56
Functional neuroimaging in de novo Parkinson's disease with REM sleep behaviour disorder 56
Evidence of posterior cortical dysfunction in de novo, drug-naïve Parkinson’s disease (PD) 55
REMeDio: a proof-of-concept neuroprotection study for prodromal synucleinopathies 54
The 16 item-printed word version of the free and cued selective reminding test (FCSRT): normal values in an italian population 49
Neuroprogression as an illness trajectory in bipolar disorder: A selective review of the current literature 47
Polysomnographic correlates of sleep disturbances in de novo, drug naïve Parkinson's Disease 46
Cuneus/precuneus as a central hub for brain functional connectivity of mild cognitive impairment in idiopathic REM sleep behavior patients 44
Stratification Tools for Disease-Modifying Trials in Prodromal Synucleinopathy 44
The Role of Hub and Spoke Regions in Theory of Mind in Early Alzheimer’s Disease and Frontotemporal Dementia 39
The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort 38
Dopaminergic and Serotonergic Degeneration and Cortical [18 F]Fluorodeoxyglucose Positron Emission Tomography in De Novo Parkinson's Disease 35
Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages 31
Discrepancy Between Patient and Caregiver Estimate of Apathy Predicts Dementia in Patients with Amnestic Mild Cognitive Impairment 25
Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease 20
The short cognitive evaluation battery (SCEB): Italian Validation 20
Totale 8.805
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.702
article - articoli 22.187
book - libri 0
conference - conferenze 5.093
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 422
Totale 55.404
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.009 0 0 82 135 188 216 330 143 213 393 227 82
2020/2021696 37 74 61 65 26 54 56 57 57 75 64 70
2021/20221.226 32 66 114 151 52 83 67 256 50 116 50 189
2022/20231.355 102 95 21 147 211 222 4 116 248 18 148 23
2023/2024785 44 104 10 91 68 139 52 42 40 22 53 120
2024/2025261 82 164 15 0 0 0 0 0 0 0 0 0
Totale 8.872